BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 6244677)

  • 1. Markers of human lymphocyte subpopulations in primary immunodeficiency and lymphoproliferative disorders.
    Gupta S; Good RA
    Semin Hematol; 1980 Jan; 17(1):1-29. PubMed ID: 6244677
    [No Abstract]   [Full Text] [Related]  

  • 2. Human lymphocyte subpopulations.
    Vogler LB; Grossi CE; Cooper MD
    Prog Hematol; 1979; 11():1-45. PubMed ID: 230533
    [No Abstract]   [Full Text] [Related]  

  • 3. T- and B-lymphocytes in immunological disorders.
    Yata J; Okumura K; Nakagawa T; Sumiya M
    Allerg Immunol (Leipz); 1974-1975; 20-21(4):403-12. PubMed ID: 4377862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunologic cell markers in lymphoproliferative diseases].
    Samoĭlova RS
    Ter Arkh; 1980; 52(9):140-9. PubMed ID: 7001662
    [No Abstract]   [Full Text] [Related]  

  • 5. Human lymphocyte differentiation markers and their application to immune deficiency and lymphoproliferative diseases.
    Siegal FP; Good RA
    Clin Haematol; 1977 Jun; 6(2):355-422. PubMed ID: 334421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Summary: symposium on Epstein-Barr virus-induced lymphoproliferative diseases in immunodeficient patients.
    Klein G; Purtilo D
    Cancer Res; 1981 Nov; 41(11 Pt 1):4302-4. PubMed ID: 6272974
    [No Abstract]   [Full Text] [Related]  

  • 7. The T cell circuit: clinical and biological implications.
    Romain PL; Schlossman SF
    Adv Intern Med; 1986; 31():1-16. PubMed ID: 2868620
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of lymphocyte differentiation in primary and secondary immunodeficiency diseases.
    Tedder TF; Crain MJ; Kubagawa H; Clement LT; Cooper MD
    J Immunol; 1985 Sep; 135(3):1786-91. PubMed ID: 3160779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subpopulations of human T lymphocytes. V. T lymphocytes with receptors for immunoglobulin M or G in patients with primary immunodeficiency disorders.
    Gupta S; Good RA
    Clin Immunol Immunopathol; 1978 Nov; 11(3):292-302. PubMed ID: 309372
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of human lymphocyte subpopulations by surface marker analysis.
    Ross GD
    Blood; 1979 May; 53(5):799-811. PubMed ID: 219922
    [No Abstract]   [Full Text] [Related]  

  • 11. Lymphocyte surface markers.
    Thomson AW
    Scott Med J; 1979 Apr; 24(2):118-20. PubMed ID: 315100
    [No Abstract]   [Full Text] [Related]  

  • 12. Current concepts in immunology: Cell-surface markers in lymphoproliferative disease.
    Aisenberg AC
    N Engl J Med; 1981 Feb; 304(6):331-6. PubMed ID: 6969365
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of human peripheral blood lymphocyte cells on the basis of surface properties.
    Negro Alvarez JM
    Allergol Immunopathol (Madr); 1980; 8(6):679-84. PubMed ID: 7010971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human thymus lymphoid tissue (HTL) antigen, complement receptor and rosette formation with sheep erythrocytes of the lymphocytes from primary immunodeficiency diseases.
    Yata J; Tsukimoto I; Arimoto T; Goya N; Tachibana T
    Clin Exp Immunol; 1973 Jul; 14(3):309-17. PubMed ID: 4579777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of responsiveness in lymphocytes of immunodeficient patients' cells implanted with foreign plasma membranes.
    Levy D; Porat Y; Pick I; Handzel ZT; Schlesinger M; Tanay A; Zan-Bar I
    Immunodeficiency; 1993; 4(1-4):43-6. PubMed ID: 8167731
    [No Abstract]   [Full Text] [Related]  

  • 16. The lymphoid system: abnormalities in immunodeficiency and malignancy.
    Kersey JH; Gajl-Peczalska KJ; Nesbit ME
    J Pediatr; 1974 Jun; 84(6):789-96. PubMed ID: 4596997
    [No Abstract]   [Full Text] [Related]  

  • 17. Rosette formation with mouse erythrocytes. III. Studies in patients with primary immunodeficiency and lymphoproliferative disorders.
    Gupta S; Good RA; Siegal FP
    Clin Exp Immunol; 1976 Nov; 26(2):204-13. PubMed ID: 1068759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal lymphocyte subsets of X-linked lymphoproliferative syndrome.
    Seeley J; Sakamoto K; Ip SH; Hansen PW; Purtilo DT
    J Immunol; 1981 Dec; 127(6):2618-20. PubMed ID: 6271875
    [No Abstract]   [Full Text] [Related]  

  • 19. The relationship between Epstein-Barr virus and lymphoma.
    Bird AG; Britton S
    Semin Hematol; 1982 Oct; 19(4):285-300. PubMed ID: 6297094
    [No Abstract]   [Full Text] [Related]  

  • 20. Modification of emerging repertoires by immunosuppression in immunodeficient mice results in autoimmunity.
    Marcos MA; de la Hera A; Gaspar ML; Márquez C; Bellas C; Mampaso F; Toribio ML; Martínez C
    Immunol Rev; 1986 Dec; 94():51-74. PubMed ID: 3100422
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.